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Abstract. The present studies have the purpose to in house validation of the ELISA tests used in 
diagnosis of fallowing viral diseases: avian influenza (AI), classical swine fever (CSF), porcine reproductive and 
respiratory syndrome (PRRS), bovine viral diarrhea- mucosal disease (BVD-MD), bovine infectious 
rhinotracheitis (BIR) and enzootic bovine leukosis (EBL). The samples used was: chicken positive serum, 
porcine positive serum for CSF and positive serum for PRRS, bovine positive serum for BIR, bovine negative 
serum for EBL, bovine positive serum for BVD-MD, positive control, negative control, serial and successive 
dilution of positive control. The performance parameters had the fallowing results: for AI the repeatability (r) for 
optical densities (DOP) 0.055, DOP intermediate precision (R) 0.0927, sensitivity (p+) and specificity (p-) 1 
(100%); for CSF DOP r=0.0277, DOP R=0.0754, p+=1, p-=1; for PRRS DOP r=0.0877, DOP R=0.1589, p+=1, 
p-=1; for BVD-MD DOP r=0.0277, DOP R=0.0921, p+=1, p-=1; for BIR DOP r=0.0182; DOP R=0.0807, p+=1, 
p-=1, for EBL DOP r= 0.032, DOP R=0.0858, p+=1, p-=1. Considering these results, the validation protocol 




To assure a valid result from a measurement test is one of mainly purpose. Because in 
the course of the test, many uncertainty factors can be involved, and many of them cannot be 
appreciating, a validation protocol is mandatory.  
MATERIAL AND METHOD 
 
The different samples had been tested through: Avian Influenza A Blocking ELISA® 
Institut Pourquier for AI, Cedi Test CSFV ® Cedi Diagnostics B.V. for CSF, Porcine 
Reproductive and Respiratory Syndrome Virus Antibody Test Kit ® IDEXX Laboratories for 
PRRS, Cedi Test BVDV ® Cedi Diagnostics B.V for BVD-MD, HerdCheck Infectious 
Bovine Rhinotracheitis Virus (BHV1) gB Antibody ELISA Test Kit ® IDEXX Laboratories 
for BIR, ELISA Bovine Leukosis Serum Monocupule ® Institut Pourquier. The assay made 
according the manufacturer specification. In the absence of certified positive control sample, 
we considered arbitrary the positive control from the each kit, and from it, made a serial and 
successive dilution. The equipment, computer systems and software used are also according 
with manufacturer instructions. All equipment had been calibrated previously.  
The samples tested for AI was: no.1 chicken serum positive tested before in 20 replica, 
no.2 positive control from the kit in 4 replica – certified by ICPBMV with positively even at 
1/8 dilution with mean DOP 0.342, no.3 negative control from the kit in 6 replica, no.4-13 
represented by 10 serial dilution of the positive control 1/1, ¼, 1/8, 1/16, 1/32, 1/64, 1/128, 
1/256, 1/512 in 2 replica each, no.14-22 represented by 9 successive dilution of the positive 
control 1/1, ½, 1/3, ¼, 1/5, 1/6, 1/7, 1/8, 1/9 in 2 replica each. Two different operators had 
tested a two lot with 10 replicas from sample 1, 2 replicas from sample 2 and 3 sample from 
sample 3 each, in different days. The first operator tested the samples no. 4-22.  
The samples tested for CSF was: no.1 porcine serum positive tested before in 20 
replica, no. 2 blank- distillate water in 6 replica, no.3 positive control from the kit in 6 replica, 
no.4 negative control from the kit in 6 replica, no.5-11 represented by 7 serial dilution of the 
positive control 1/1, ½, ¼, 1/8, 1/16, 1/32, 1/64 in 2 replica each, no.12-27 represented by 16 
successive dilution of the positive control 1/1, ½, 1/3, ¼, 1/5, 1/6, 1/7, 1/8, 1/9, 1/10, 1/11, 
1/12, 1/13, 1/14, 1/15, 1/16 in 2 replica each. Two different operators had tested a two lot with 
10 replicas from sample 1, 3 replicas from sample 2, 3 and 4 each, in different days. The first 
operator tested the samples no. 4-27. 
The samples tested for PRRS was: no.1 porcine serum positive tested before, in 20 
replica, no.2 positive control from the kit in 4 replica, no.3 negative control from the kit in 4 
replica, no.4-11 represented by 8 serial dilution of the positive control 1/1, ½, ¼, 1/8, 1/16, 
1/32, 1/64, 1/128 in 2 replica each. Two different operators had tested a two lot with 10 
replicas from sample 1, 2 replicas from sample 2 and 3 each, in different days. The first 
operator tested the samples no. 4-11. 
The samples tested for BVD-MD was: no.1 bovine serum positive tested before in 20 
replica, no.2 blank distillate water in 3 replica, no.3 positive control from the kit in 5 replica, 
no.4 negative control from the kit in 5 replica, no.5-12 represented by 8 serial dilution of the 
positive control 1/1, ½, ¼, 1/8, 1/16, 1/32, 1/64 in 2 replica each. A lot with 10 replicas from 
sample 1, 3 replicas from sample the first operator had tested 2 and 3, and all samples 5-12, 
and a lot with 10 replicas from sample 1 and 2 replicas from sample 2 and 3, had tested by the 
second operator in different days.  
The samples tested for BIR was: no.1 bovine serum positive tested before in 20 
replica, no. 2 positive control from the kit in 5 replica, no.3 negative control from the kit in 5 
replica, no.4-11 represented by 8 serial dilution of the positive control 1/1, ½, ¼, 1/8, 1/16, 
1/32, 1/64, 1/128 in 2 replica each, no.12-20 represented by 9 successive dilution of the 
positive control 1/1, ½, 1/3, ¼, 1/5, 1/6, 1/7, 1/8, 1/9, in 2 replica each. The first lot with 10 
replicas from sample 1, 3 replicas from sample 2 and 3 and all replicas of samples 4-20 had 
tested by the first operator and lot with 10 replicas from sample 1, 2 replicas from sample 2 
and 3 had tested by the second operator. 
The samples tested for EBL was: no.1 bovine serum negative tested before in 20 
replica, no. 2 blank- distillate water in 3 replica, no.3 positive control from the kit in 5 replica, 
no.4 negative control from the kit in 4 replica, no.5-12 represented by 8 serial dilution of the 
positive control 1/1, ½, ¼, 1/8, 1/16, 1/32, 1/64, 1/128 in 2 replica each, no.13-21 represented 
by 9 successive dilution of the positive control 1/1, ½, 1/3, ¼, 1/5, 1/6, 1/7, 1/8, 1/9, in 2 
replica each. A first lot with 10 replicas from sample 1, 2 replicas from sample 3 and 4, and 
the all replicas of the samples 5-21 had been tested by the first operator. The second lot with 
10 replicas from sample 1, 2 replicas from sample 4, 3 replicas from samples 2 and had tested 
by the second operator. 
The results were divide in true positive N11; false positive N21; false negative N12; 
true negative 22. The performance of the method has appreciated through repeatability, 
intermediate precision, accuracy, sensitivity, specificity, Chi square, linearity, detection limit 
and quantification limit. For mathematical evaluation, we used MS Office Excel software.  
RESULTS AND DISCUSIONS 
 
Repeatability (r) expresses the precision under the same operation condition over a 
short interval of time, and represents the closest extreme in an independent measurement with 







t5%  = Student coefficient 


















The logical value had transformed in numeric value: each logical false value became 
value 0 and each true value become value 1. All kits had SD (standard deviation) =0.00, 
implicit r (repeatability) =0.00, for each set, cu repeatability limit = 1 (true value) ±0. 
The calculation of repeatability in using the values of optical densitie are presented in 
the 0. 
Intermediate precision (R) had been calculated by multiplying the repeatability with 
1.6 an accepted coefficient. The results are qualitative and expressed like positive and 
negative. The logical value had transformed in numeric value: each logical false value became 
value 0 and each true value become value 1. The all kits had SD R(standard deviation) =0,00, 
implicit R (intermediary precision) =0,00, for each set, cu intermediary precision limit = 1 
(true value) ±0. 
The calculation of intermediate precision using the values of optical densities (DOP), 
are showed in 0. 
The accuracy (AC) is sometimes termed trueness, and result from the comparison of 










The Chi-square ( 2) [5] reveal whether hypothesized results are verified by an 












The sensitivity (p+/SE) [P(T+|D+)]calculated had been 1 for all ELISA kit, or can be 
expressed like 100% and reveal the probability that a true positive sample will be tested 
positive. p+=1, SE=100% [6] 
The performance indicator after general classification of the samples 
 The obtained results 
 
The samples status 
test POSITIVE Negative 
Total 
 POSITIVE N11 N12 N1⋅ 
 Negative N21 N22 N2⋅ 
 Total N
⋅1 N⋅2 N= N1⋅ + N1⋅ or N⋅1 + N⋅2  
 
N11= true positive;  N12 = false negative;  N21 =false positive;  N22 =true negative  
The specificity (p-/SP) [P(T-|D-)]calculated had been 1 for all ELISA kit ,or can be 
expressed like 100% and reveal the probability that a true negative sample will be tested 

















Positive predictive value (Ppv)(D+|T+)=N11/(N11+N21) is the proportion of positive test 
sample it is true positive, and it is 1 for all ELISA kit. 
Negative predictive value (Npv)(D-|T-)=N22/(N22+N12) is the proportion of negative 
test sample it is true negative, and it is 1 for all ELISA kit. 
False positive rate pf+ is the proportion of negative instances that were erroneously 
reported as being positive .It is equal to 1 minus the specificity of the test: pf+=0 for all 
ELISA kit.[9] 
False negative rate pf- is the proportion of positive instances that were erroneously 


















The detection limit had been estabileshed arbitrary in many instances at serial dilution 
of positive control, because don’t had been obatained any doubtful result, and at a specifice 
dilution. 
The quantification limit had been estabileshed at the lower dilution of positive control 
that react as positive. 
The DOP obtained from the serial and successive dilution of the positive control from 
all the kit, revealed a cvasilinear rising proportional related with the analite concentration, the 
fact could let to consider that the assays have linearity.  



















N11= true positive 24 26 24 25 25 5 
N12 = false negative 0 0 0 0 0 0 
N21 =false positive 0 0 0 0 0 0 
N22 =true negative 6 6 4 8 5 27 
N
⋅1= total positive 
results obtained 
24 26 24 25 25 5 
N
⋅2= total negative 
results obtained 
6 6 4 8 5 27 
N1⋅= total true positive 
sample 
24 26 24 25 25 5 
N2⋅= total true negative 
sample 
6 6 4 8 5 27 
Xr (mean) 0.33 0.235 0.783 0.1515 0.094 0.064 0.203 
SDr 0.02
49 
0.0124 0.0393 0.00903 0.0090 0.0081 0.0144 
r 0.05
55 



















0.0530 0.0503 0.0115 0.0953 0.1270 0.0708 
XR 0.31 0.247 0.807 0.152 0.088 0.041 0.186 
SDR 0.02
77 
0.0225 0.0475 0.0082 0.0275 0.0241 0.0257 
R 0.09
27 


















0.0912 0.0589 0.0541 0.3133 0.5842 0.1379 
AC 1 







Detection Limit  (Ld) 1/10 1/6 ½ 1/1 1/10 1/0 
Quantification Limit (Lq) 1/9 1/9 1/1 1/0 1/9 1/0 
Linearity present 
 
The performance indicators  
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Fig. 1 The distribution of DOP proportional with dilution 
avian influenza ELISA test 
Fig. 2 The distribution of DOP proportional with dilution 
classical swin fever ELISA test 
 
AI DILUTION DOP CSF DILUTION DOP SRRP DILUTION 
DOP Ag 
SRRP 
1 0,500 0,095 1 0,500 0,070 1 0,500 0,282 
2 0,330 0,107 2 0,330 0,171 2 0,330 0,163 
3 0,250 0,113 3 0,250 0,322 4 0,200 0,115 
4 0,200 0,136 4 0,200 0,476 8 0,111 0,080 
5 0,166 0,129 5 0,166 0,641 16 0,058 0,068 
6 0,142 0,134 6 0,142 0,785 32 0,030 0,062 
7 0,125 0,140 7 0,125 0,986 64 0,015 0,052 
8 0,111 0,194 8 0,111 1,068 
9 0,100 0,178 9 0,100 1,319 
16 0,058 0,579 10 0,090 1,336 
32 0,030 0,731 11 0,083 1,465 
64 0,015 0,886 12 0,076 1,554 
128 0,008 0,910 13 0,071 1,752 
   14 0,066 1,899 
   15 0,063 1,920 
   16 0,058 2,010 
 
BVD DILUTION DOP IBR DILUTION DOP LEB DILUTION DOP 
1 0,500 0,904 1 0,500 0,217 1 0,500 0,797 
2 0,330 1,304 2 0,330 0,516 2 0,330 0,587 
3 0,250 1,600 4 0,200 0,937 3 0,250 0,472 
4 0,200 1,639 8 0,111 1,278 4 0,200 0,451 
5 0,166 1,672 16 0,058 1,515 5 0,166 0,412 
6 0,142 1,699 32 0,030 1,579 6 0,142 0,388 
7 0,125 1,678 64 0,015 1,634 7 0,125 0,354 
8 0,111 1,704 128 0,008 1,712 8 0,111 0,338 
      9 0,100 0,339 
The linearity of ELISA assay in avian influenza, classical swine fever, and PRRS 
The linearity of ELISA assay in bobine viral diarrhea- mucosal disease, bovine infectious rhinotracheitis, and 
enzootic bovine leukemia 
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Fig. 3 The distribution of DOP proportional with dilution bovine infectious rhinotracheitis ELISA test 
CONCLUSION 
 
The protocol revealed that the method is valid, and can be used proper in the 
laboratory for it purpose.  
The values of the standard deviation, repeatability and intermediate precision are low, 
according with our expectation. 
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